MedTrace Logo

The DefiPace Study

NCT04804748 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 450

Last updated 2026-03-30

No results posted yet for this study

Summary

Prospective, non-interventional, multi-center, international registry in two phases in consecutive patients undergoing elective cardiac surgery.

The DefiPace registry is designed in two phases

1. to document the standard of care in 50 patients with atrial fibrillation (AF)
2. to assess the treatment and outcomes of patients with post-operative atrial fibrilllation using low-energy cardioversion and subsequent bi-atrial pacing in clinical practice in 100 patients

Conditions

  • Post-operative Atrial Fibrillation POAF

Interventions

OTHER

No intervention

no intervention

Sponsors & Collaborators

  • Osypka AG

    collaborator UNKNOWN

  • Institut für Pharmakologie und Präventive Medizin

    lead NETWORK

Principal Investigators

  • Peter Bramlage, Professor · IPPMed

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-03-28
Primary Completion
2026-05-31
Completion
2026-08-31

Countries

  • Austria
  • Germany

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04804748 on ClinicalTrials.gov